FM
Family Management Portfolio holdings
AUM
$658M
This Quarter Return
+3.97%
1 Year Return
+14.42%
3 Year Return
+54.25%
5 Year Return
+91.79%
10 Year Return
+224.62%
AUM
$146M
AUM Growth
+$146M
(-17%)
Cap. Flow
-$35.3M
Cap. Flow
% of AUM
-24.15%
Top 10 Holdings %
Top 10 Hldgs %
47.65%
Holding
85
New
8
Increased
7
Reduced
34
Closed
17
Top Buys
| 1 |
Exxon Mobil
XOM
|
$2.87M |
| 2 |
Amazon
AMZN
|
$1.78M |
| 3 |
American Express
AXP
|
$1.77M |
| 4 |
Howmet Aerospace
HWM
|
$1.32M |
| 5 |
Citigroup
C
|
$841K |
Top Sells
| 1 |
AbbVie
ABBV
|
$7.02M |
| 2 |
General Dynamics
GD
|
$5.45M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.95M |
| 4 |
Hormel Foods
HRL
|
$3.93M |
| 5 |
FMC
FMC
|
$2.37M |
Sector Composition
| 1 | Technology | 21.94% |
| 2 | Healthcare | 12.54% |
| 3 | Communication Services | 11.48% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$204B
| $1.91M | 1.31% | 18,297 -755 | -4% | -$79K |
|
|
CELG
27
DELISTED
Celgene Corp
CELG
| $1.77M | 1.21% | 15,324 -700 | -4% | -$81K |
|
|
28
American Express
AXP
$231B
| $1.77M | 1.21% | +23,871 | New | +$1.77M |
|
29
Visa
V
$683B
| $1.66M | 1.13% | 21,211 -1,275 | -6% | -$99.5K |
|
|
XLNX
30
DELISTED
Xilinx Inc
XLNX
| $1.63M | 1.11% | 26,950 -25 | -0.1% | -$1.51K |
|
31
Toll Brothers
TOL
$13.4B
| $1.37M | 0.93% | 44,050 -7,725 | -15% | -$240K |
|
|
32
Howmet Aerospace
HWM
$70.2B
| $1.32M | 0.9% | +70,927 | New | +$1.32M |
|
|
ARIA
33
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.24M | 0.85% | 100,000 -250 | -0.2% | -$3.11K |
|
|
KATE
34
DELISTED
Kate Spade & Company
KATE
| $933K | 0.64% | 50,000 | – | – |
|
35
Meta Platforms (Facebook)
META
$1.86T
| $885K | 0.61% | 7,687 +1,075 | +16% | +$124K |
|
|
36
Citigroup
C
$178B
| $841K | 0.58% | +14,144 | New | +$841K |
|
37
iShares MSCI EAFE ETF
EFA
$66B
| $837K | 0.57% | 14,500 | – | – |
|
|
38
Bristol-Myers Squibb
BMY
$96B
| $611K | 0.42% | 10,455 -67,569 | -87% | -$3.95M |
|
39
Acadia Pharmaceuticals
ACAD
$4.38B
| $562K | 0.38% | 19,500 | – | – |
|
40
Chevron
CVX
$324B
| $473K | 0.32% | 4,020 | – | – |
|
41
Johnson & Johnson
JNJ
$427B
| $415K | 0.28% | 3,601 -250 | -6% | -$28.8K |
|
42
Lineage Cell Therapeutics
LCTX
$267M
| $415K | 0.28% | 115,000 +28,000 | +32% | +$101K |
|
43
Chipotle Mexican Grill
CMG
$56.5B
| $381K | 0.26% | 1,011 -275 | -21% | -$104K |
|
44
Altria Group
MO
$113B
| $365K | 0.25% | 5,394 -314 | -6% | -$21.2K |
|
45
Philip Morris
PM
$260B
| $350K | 0.24% | 3,828 +36 | +0.9% | +$3.29K |
|
46
Enterprise Products Partners
EPD
$69.6B
| $345K | 0.24% | 12,775 -48,450 | -79% | -$1.31M |
|
47
Berkshire Hathaway Class B
BRK.B
$1.09T
| $334K | 0.23% | 2,050 | – | – |
|
48
Merck
MRK
$210B
| $302K | 0.21% | 5,136 | – | – |
|
49
Amgen
AMGN
$155B
| $292K | 0.2% | 2,000 | – | – |
|
50
AT&T
T
$209B
| $282K | 0.19% | 6,631 -4,961 | -43% | -$211K |
|